Scholar Rock (SRRK) Financials

Scholar Rock logo
$50.37 +2.37 (+4.94%)
Closing price 04:00 PM Eastern
Extended Trading
$50.76 +0.40 (+0.78%)
As of 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Scholar Rock

Annual Income Statements for Scholar Rock

This table shows Scholar Rock's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-25 -49 -51 -86 -132 -135 -166 -246 -378
Consolidated Net Income / (Loss)
-25 -49 -51 -86 -132 -135 -166 -246 -378
Net Income / (Loss) Continuing Operations
-25 -51 -51 -87 -132 -135 -166 -246 -378
Total Pre-Tax Income
-25 -51 -55 -87 -130 -134 -171 -246 -378
Total Operating Income
-25 -51 -55 -87 -130 -134 -171 -252 -385
Total Gross Profit
0.00 0.00 20 15 19 33 0.00 0.00 0.00
Total Revenue
0.00 0.00 20 15 19 33 0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
25 51 75 102 149 168 171 252 385
Selling, General & Admin Expense
5.09 14 21 28 40 43 49 68 176
Research & Development Expense
20 36 54 74 108 124 122 185 208
Total Other Income / (Expense), net
0.03 0.00 0.00 0.00 0.00 0.00 0.00 5.76 6.71
Interest Expense
-0.04 - - - - - - 6.84 6.89
Interest & Investment Income
- - - - - - - 13 14
Other Income / (Expense), net
-0.01 - - - - - - -0.09 -0.30
Basic Earnings per Share
($15.30) ($3.15) ($1.85) ($2.81) ($3.59) ($2.26) ($1.99) ($2.47) ($3.29)
Weighted Average Basic Shares Outstanding
1.63M 15.66M 27.54M 30.73M 36.71M 59.61M 83.35M 99.84M 114.70M
Diluted Earnings per Share
($15.30) ($3.15) ($1.85) ($2.81) ($3.59) ($2.26) ($1.99) ($2.47) ($3.29)
Weighted Average Diluted Shares Outstanding
1.63M 15.66M 27.54M 30.73M 36.71M 59.61M 83.35M 99.84M 114.70M
Weighted Average Basic & Diluted Shares Outstanding
1.63M 15.66M 27.54M 30.73M 35.30M 51.99M 77.87M 94.68M 114.88M

Quarterly Income Statements for Scholar Rock

This table shows Scholar Rock's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-57 -59 -64 -66 -75 -110 -102 -91 -106 -110 -107
Consolidated Net Income / (Loss)
-57 -59 -64 -66 -75 -110 -102 -91 -106 -110 -107
Net Income / (Loss) Continuing Operations
-57 -59 -64 -72 -75 -110 -102 -91 -106 -111 -107
Total Pre-Tax Income
-58 -59 -64 -69 -75 -110 -102 -89 -102 -110 -107
Total Operating Income
-58 -59 -65 -69 -77 -112 -104 -92 -102 -109 -106
Total Gross Profit
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.56
Total Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.57
Operating Revenue
- 0.00 - - - - 0.00 - - - 0.57
Total Cost of Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.01
Operating Cost of Revenue
- - - - - - 0.00 - - - 0.01
Total Operating Expenses
58 59 65 69 77 112 104 92 102 109 107
Selling, General & Admin Expense
15 17 16 19 28 50 53 45 50 51 52
Research & Development Expense
43 42 49 50 49 62 50 47 52 58 54
Total Other Income / (Expense), net
0.00 0.99 0.30 - 2.37 2.08 1.33 3.30 -0.16 -1.00 -1.18
Interest Expense
- 1.72 1.74 - 1.82 1.21 1.33 - 2.30 4.52 4.63
Interest & Investment Income
- 2.72 2.08 - 4.23 3.41 2.73 - 2.94 4.09 4.10
Other Income / (Expense), net
- -0.01 -0.04 - -0.04 -0.13 -0.07 - -0.79 -0.57 -0.64
Basic Earnings per Share
($0.59) ($0.60) ($0.66) ($0.62) ($0.67) ($0.98) ($0.90) ($0.74) ($0.83) ($0.84) ($0.81)
Weighted Average Basic Shares Outstanding
95.89M 96.81M 97.05M 99.84M 111.84M 112.70M 113.73M 114.70M 127.28M 130.61M 132.37M
Diluted Earnings per Share
($0.59) ($0.60) ($0.66) ($0.62) ($0.67) ($0.98) ($0.90) ($0.74) ($0.83) ($0.84) ($0.81)
Weighted Average Diluted Shares Outstanding
95.89M 96.81M 97.05M 99.84M 111.84M 112.70M 113.73M 114.70M 127.28M 130.61M 132.37M
Weighted Average Basic & Diluted Shares Outstanding
79.75M 80.03M 93.61M 94.68M 94.95M 96.13M 102.01M 114.88M 119.83M 121.79M 122.00M

Annual Cash Flow Statements for Scholar Rock

This table details how cash moves in and out of Scholar Rock's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
46 59 -76 124 52 -110 -1.51 76 147
Net Cash From Operating Activities
-22 25 -63 -60 -127 -133 -145 -201 -300
Net Cash From Continuing Operating Activities
-22 25 -63 -60 -127 -133 -145 -201 -300
Net Income / (Loss) Continuing Operations
-25 -49 -51 -86 -132 -135 -166 -246 -378
Consolidated Net Income / (Loss)
-25 -49 -51 -86 -132 -135 -166 -246 -378
Depreciation Expense
0.67 0.80 1.30 1.49 2.63 2.99 2.84 1.94 1.66
Amortization Expense
-0.01 -0.35 -1.39 -0.10 1.25 5.48 -5.95 -5.04 -3.57
Non-Cash Adjustments To Reconcile Net Income
1.49 5.21 8.07 12 30 28 26 42 75
Changes in Operating Assets and Liabilities, net
1.11 68 -20 13 -28 -34 -2.76 6.59 4.72
Net Cash From Investing Activities
18 -60 -62 -63 134 -172 41 -76 219
Net Cash From Continuing Investing Activities
18 -60 -62 -63 134 -172 41 -76 219
Purchase of Property, Plant & Equipment
-0.36 -1.49 -3.12 -4.09 -5.25 -1.06 -0.07 -0.10 -0.60
Purchase of Investments
- -75 -235 -200 -60 -301 -291 -293 -98
Sale and/or Maturity of Investments
18 17 176 141 200 130 332 217 317
Net Cash From Financing Activities
51 94 49 248 45 195 103 353 228
Net Cash From Continuing Financing Activities
51 94 49 248 45 195 103 353 228
Repayment of Debt
-0.68 -0.67 -0.38 -0.02 -0.02 -0.98 0.00 -0.13 -26
Issuance of Debt
- - 0.00 25 25 - - 0.00 75
Issuance of Common Equity
- 95 48 216 13 195 98 324 92
Other Financing Activities, net
- 0.01 0.91 7.29 6.89 0.49 4.86 29 88
Effect of Exchange Rate Changes
- - - - - - - 0.00 -0.00
Cash Interest Paid
0.05 - 0.00 0.25 2.08 4.37 6.40 6.62 6.07

Quarterly Cash Flow Statements for Scholar Rock

This table details how cash moves in and out of Scholar Rock's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-9.88 1.39 -17 101 -40 15 135 37 106 7.31 -71
Net Cash From Operating Activities
-50 -49 -52 -50 -79 -77 -69 -75 -82 -70 -82
Net Cash From Continuing Operating Activities
-50 -49 -52 -50 -79 -77 -69 -75 -82 -70 -82
Net Income / (Loss) Continuing Operations
-57 -59 -64 -66 -75 -110 -102 -91 -106 -110 -107
Consolidated Net Income / (Loss)
-57 -59 -64 -66 -75 -110 -102 -91 -106 -110 -107
Depreciation Expense
0.60 0.50 0.45 0.40 0.39 0.42 0.42 0.43 0.34 0.30 0.26
Amortization Expense
-1.84 -1.26 -0.64 -1.30 -0.22 -1.38 -0.63 -0.10 -0.14 -0.03 -0.23
Non-Cash Adjustments To Reconcile Net Income
9.78 7.31 9.33 9.17 13 26 15 20 22 21 19
Changes in Operating Assets and Liabilities, net
-1.46 2.76 2.89 8.68 -18 8.33 18 -4.41 1.53 18 6.89
Net Cash From Investing Activities
33 51 35 -195 35 85 60 39 -5.34 -5.50 7.94
Net Cash From Continuing Investing Activities
33 51 35 -195 35 85 60 39 -5.34 -5.50 7.94
Purchase of Property, Plant & Equipment
-0.02 -0.02 -0.03 -0.02 -0.27 -0.22 -0.08 -0.03 -0.07 -0.00 -0.10
Purchase of Investments
-35 -33 -14 -210 -58 -21 -19 - -25 -43 -3.96
Sale and/or Maturity of Investments
68 84 50 15 93 107 79 39 20 38 12
Net Cash From Financing Activities
6.53 -0.03 0.17 346 4.17 6.47 144 73 194 83 3.13
Net Cash From Continuing Financing Activities
6.53 -0.03 0.17 346 4.17 6.47 144 73 194 83 3.13
Repayment of Debt
0.00 -0.08 -0.05 - -26 - - -0.00 -104 -1.20 -0.61
Other Financing Activities, net
6.53 0.05 0.21 22 5.02 6.47 2.82 73 3.47 21 3.73
Effect of Exchange Rate Changes
- - - - 0.00 - - - 0.67 -0.76 -0.09
Cash Interest Paid
1.66 1.67 1.67 1.61 1.50 1.26 1.28 2.03 2.37 2.03 6.83

Annual Balance Sheets for Scholar Rock

This table presents Scholar Rock's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
62 181 196 388 304 358 311 475 404
Total Current Assets
59 178 185 344 265 328 288 451 385
Cash & Equivalents
56 115 36 160 213 103 102 178 324
Short-Term Investments
1.50 61 121 181 40 212 178 259 44
Accounts Receivable
- - 25 - - - - - 0.00
Inventories, net
- - - - - - - - 0.00
Prepaid Expenses
1.24 2.30 2.72 3.37 12 13 8.26 14 18
Plant, Property, & Equipment, net
2.18 3.19 4.17 8.12 9.56 7.38 4.60 2.76 1.71
Total Noncurrent Assets
0.26 0.21 7.04 36 30 23 18 21 17
Other Noncurrent Operating Assets
0.26 0.21 7.04 36 30 23 18 21 17
Total Liabilities & Shareholders' Equity
62 181 196 388 304 358 311 475 404
Total Liabilities
5.93 75 83 128 132 98 86 106 159
Total Current Liabilities
5.02 31 33 43 64 36 33 47 55
Accounts Payable
1.36 3.30 1.13 3.41 4.43 3.99 3.47 10 10
Accrued Expenses
2.80 7.16 9.61 15 17 24 20 31 40
Other Current Liabilities
- 0.01 1.15 5.38 7.64 8.07 7.49 5.77 5.55
Total Noncurrent Liabilities
0.90 44 51 85 68 62 53 59 103
Long-Term Debt
0.40 0.02 0.00 25 48 50 49 50 100
Other Noncurrent Operating Liabilities
0.04 - 4.18 27 20 12 4.39 9.21 3.66
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-54 107 113 261 172 260 225 369 245
Total Preferred & Common Equity
-54 107 113 261 172 260 225 369 245
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-54 107 113 261 172 260 225 369 245
Common Stock
4.01 213 271 505 548 772 902 1,291 1,546
Retained Earnings
-58 -107 -158 -244 -376 -511 -676 -923 -1,301
Accumulated Other Comprehensive Income / (Loss)
-0.00 -0.01 0.04 -0.00 -0.04 -0.88 0.09 0.16 0.09

Quarterly Balance Sheets for Scholar Rock

This table presents Scholar Rock's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
285 251 267 227 179 408 340 412 535 524 446
Total Current Assets
260 228 247 199 153 385 319 391 515 507 433
Cash & Equivalents
108 68 92 93 76 138 153 287 431 437 366
Short-Term Investments
141 151 146 97 63 226 142 83 49 55 47
Accounts Receivable
- - - - - - - - - - 0.68
Inventories, net
- - - - - - - - - - 0.77
Prepaid Expenses
11 9.83 8.50 8.64 14 21 24 21 35 15 18
Plant, Property, & Equipment, net
5.99 5.28 4.04 3.55 3.16 2.64 2.44 2.12 1.44 1.17 0.98
Total Noncurrent Assets
19 17 16 24 23 20 18 19 19 15 12
Other Noncurrent Operating Assets
19 17 16 24 23 20 18 19 19 15 12
Total Liabilities & Shareholders' Equity
285 251 267 227 179 408 340 412 535 524 446
Total Liabilities
82 83 85 93 100 95 107 167 259 270 277
Total Current Liabilities
24 27 38 33 39 38 50 62 60 72 80
Accounts Payable
3.04 1.97 2.87 3.32 4.07 4.44 1.10 6.77 9.22 11 6.16
Accrued Expenses
14 17 21 22 29 28 44 50 44 55 68
Other Current Liabilities
7.42 7.37 7.73 6.20 6.04 5.50 5.21 5.33 6.08 6.32 5.82
Total Noncurrent Liabilities
58 56 47 60 61 58 56 105 200 198 197
Long-Term Debt
50 50 45 48 50 50 50 100 197 196 196
Other Noncurrent Operating Liabilities
8.23 6.34 2.41 12 10 7.91 6.56 5.14 2.98 1.31 0.96
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
203 168 183 134 79 312 233 245 276 254 169
Total Preferred & Common Equity
203 168 183 134 79 312 233 245 276 254 169
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
203 168 183 134 79 312 233 245 276 254 169
Common Stock
791 798 916 925 935 1,310 1,341 1,455 1,681 1,769 1,790
Retained Earnings
-588 -630 -733 -792 -856 -997 -1,107 -1,210 -1,406 -1,516 -1,623
Accumulated Other Comprehensive Income / (Loss)
-0.06 -0.02 -0.05 -0.05 0.13 0.13 0.06 0.12 0.69 1.14 1.62

Annual Metrics And Ratios for Scholar Rock

This table displays calculated financial ratios and metrics derived from Scholar Rock's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - 102,007,457.00
DEI Adjusted Shares Outstanding
- - - - - - - - 102,007,457.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - -3.71
Growth Metrics
- - - - - - - - -
Profitability Metrics
- - - - - - - - -
Net Operating Profit after Tax (NOPAT)
-18 -35 -38 -61 -91 -94 -120 -176 -269
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - -43.57% -42.13% -78.00%
Earnings before Interest and Taxes (EBIT)
-25 -51 -55 -87 -130 -134 -171 -252 -385
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-24 -50 -55 -85 -126 -126 -174 -255 -387
Valuation Ratios
- - - - - - - - -
Leverage & Solvency
- - - - - - - - -
Liquidity Ratios
- - - - - - - - -
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 32 -62 -50 -116 -120 -121 -163 -265
Efficiency Ratios
- - - - - - - - -
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
-1.21 -69 -45 -56 -31 -5.38 -4.70 -18 -22
Increase / (Decrease) in Invested Capital
0.00 -67 24 -11 25 26 0.68 -14 -3.87
Book Value per Share
($32.75) $4.22 $3.80 $7.75 $4.90 $5.04 $3.12 $3.94 $2.41
Tangible Book Value per Share
($32.75) $4.22 $3.80 $7.75 $4.90 $5.04 $3.12 $3.94 $2.41
Total Capital
57 107 113 285 222 310 275 419 345
Total Debt
1.04 0.45 0.00 25 50 50 50 50 100
Total Long-Term Debt
0.40 0.02 0.00 25 48 50 49 50 100
Net Debt
-57 -175 -157 -316 -203 -266 -230 -387 -268
Capital Expenditures (CapEx)
0.36 1.49 3.11 4.09 5.25 1.06 0.06 0.10 0.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3.14 -28 -5.10 -39 -50 -24 -23 -33 -38
Debt-free Net Working Capital (DFNWC)
55 147 152 302 203 292 257 404 330
Net Working Capital (NWC)
54 147 152 302 201 292 255 404 330
Net Nonoperating Expense (NNE)
7.47 14 13 26 41 40 46 70 109
Net Nonoperating Obligations (NNO)
-57 -175 -157 -316 -203 -266 -230 -387 -268
Total Depreciation and Amortization (D&A)
0.66 0.46 -0.09 1.39 3.88 8.46 -3.10 -3.10 -1.91
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
($15.30) ($3.15) ($1.85) ($2.81) ($3.59) ($2.26) ($1.99) ($2.47) ($3.29)
Adjusted Weighted Average Basic Shares Outstanding
1.63M 26.22M 29.81M 34.26M 36.71M 59.61M 83.35M 99.84M 114.70M
Adjusted Diluted Earnings per Share
($15.30) ($3.15) ($1.85) ($2.81) ($3.59) ($2.26) ($1.99) ($2.47) ($3.29)
Adjusted Weighted Average Diluted Shares Outstanding
1.63M 26.22M 29.81M 34.26M 36.71M 59.61M 83.35M 99.84M 114.70M
Adjusted Basic & Diluted Earnings per Share
($15.30) ($3.15) ($1.85) ($2.81) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.63M 15.66M 27.54M 30.73M 35.30M 51.99M 77.87M 94.68M 114.88M
Normalized Net Operating Profit after Tax (NOPAT)
-18 -35 -38 -61 -91 -94 -120 -176 -269
Debt Service Ratios
- - - - - - - - -
Payout Ratios
- - - - - - - - -

Quarterly Metrics And Ratios for Scholar Rock

This table displays calculated financial ratios and metrics derived from Scholar Rock's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - 102,007,457.00 114,883,096.00 119,828,338.00 121,785,282.00
DEI Adjusted Shares Outstanding
- - - - - - - 102,007,457.00 114,883,096.00 119,828,338.00 121,785,282.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - -0.89 -0.92 -0.92 -0.88
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
EBITDA Growth
-45.33% -68.22% -34.19% -43.09% -30.99% -87.81% -59.71% - -33.33% 2.42% -0.29%
EBIT Growth
-44.21% -52.24% -48.33% -44.40% -31.96% -88.59% -59.86% - -33.28% 2.46% -2.97%
NOPAT Growth
-44.21% -52.24% -48.33% -44.40% -31.96% -88.42% -59.85% - -32.33% 2.86% -2.42%
Net Income Growth
-44.37% -54.27% -52.22% -44.07% -31.43% -88.06% -58.53% - -41.20% 0.12% -4.91%
EPS Growth
-20.41% -27.66% -24.53% -24.00% -13.56% -63.33% -36.36% - -23.88% 14.29% 10.00%
Operating Cash Flow Growth
-15.63% -51.14% -62.54% -32.57% -58.03% -56.40% -31.39% - -4.35% 8.62% -18.69%
Free Cash Flow Firm Growth
-58.66% -42.91% -24.54% -1.32% -78.10% -135.13% -56.42% - -16.02% 37.13% 11.66%
Invested Capital Growth
-273.98% -285.41% -866.37% -293.41% 58.64% -75.92% -156.13% - -217.99% -251.90% -94.66%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-21.50% -1.00% -7.82% -8.14% -11.23% -44.84% 8.28% - -12.05% -6.43% 2.32%
EBIT Q/Q Growth
-21.63% -1.85% -8.88% -7.07% -11.15% -45.59% 7.68% - -11.87% -6.48% 2.53%
NOPAT Q/Q Growth
-21.63% -1.85% -8.88% -7.07% -11.15% -45.43% 7.63% - -11.01% -6.75% 2.61%
Net Income Q/Q Growth
-23.26% -2.91% -10.21% -3.06% -12.44% -47.25% 7.10% - -15.99% -4.16% 2.42%
EPS Q/Q Growth
-18.00% -1.69% -10.00% 6.06% -8.06% -46.27% 8.16% - -12.16% -1.20% 3.57%
Operating Cash Flow Q/Q Growth
-33.30% 1.18% -6.62% 5.61% -58.90% 2.20% 10.42% - -8.75% 14.37% -16.36%
Free Cash Flow Firm Q/Q Growth
6.33% 2.96% -17.34% 5.01% -64.66% -28.11% 21.94% - -9.82% 30.58% -9.68%
Invested Capital Q/Q Growth
-18.33% -22.23% -43.66% -89.33% 87.56% -419.95% -109.16% - 67.29% -475.39% -15.70%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 98.60%
EBITDA Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -18,714.04%
Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -18,607.19%
EBIT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -18,719.47%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -18,813.86%
Tax Burden Percent
97.32% 98.34% 99.54% 95.81% 96.93% 100.00% 100.00% - 103.27% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 98.04% 98.65% - 99.38% 100.39% 100.50%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Return on Equity (ROE)
-89.09% -121.29% -183.07% -82.95% -106.71% -172.08% -218.04% - -138.94% -167.77% -199.97%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -24.88%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -25.01%
Return on Common Equity (ROCE)
-89.09% -121.29% -183.07% -82.95% -106.71% -172.08% -218.04% - -138.94% -167.77% -199.97%
Return on Equity Simple (ROE_SIMPLE)
-100.27% -152.56% -285.33% 0.00% -84.58% 0.00% 0.00% - 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-41 -42 -45 -49 -54 -78 -72 -64 -71 -76 -74
NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -13,025.04%
Net Nonoperating Expense Percent (NNEP)
-7.71% -9.94% -14.85% -5.80% -8.25% -16.36% -16.57% - -11.41% -12.44% -13.54%
Return On Investment Capital (ROIC_SIMPLE)
- - - -11.59% -14.90% -27.73% -21.03% -18.63% -15.11% -16.94% -20.35%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 1.40%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 9,209.65%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 9,496.14%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 18,705.79%
Earnings before Interest and Taxes (EBIT)
-58 -59 -65 -69 -77 -112 -104 -92 -103 -109 -107
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-60 -60 -65 -70 -78 -113 -104 -92 -103 -109 -107
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.57 4.97 8.09 10.98 9.75 14.42 14.61 - 20.46 25.97 34.89
Price to Tangible Book Value (P/TBV)
7.57 4.97 8.09 10.98 9.75 14.42 14.61 - 20.46 25.97 34.89
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 10,323.97
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 9,942.59
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.27 0.37 0.63 0.14 0.16 0.21 0.41 - 0.71 0.77 1.16
Long-Term Debt to Equity
0.24 0.36 0.63 0.14 0.16 0.21 0.41 - 0.71 0.77 1.16
Financial Leverage
-1.01 -1.01 -1.04 -1.04 -1.02 -1.05 -1.11 - -1.02 -1.11 -1.18
Leverage Ratio
1.41 1.52 1.74 1.32 1.36 1.55 1.82 - 1.60 1.77 2.07
Compound Leverage Factor
1.41 1.52 1.74 1.32 1.36 1.51 1.80 - 1.59 1.78 2.08
Debt to Total Capital
21.51% 27.26% 38.75% 11.97% 13.74% 17.58% 28.91% - 41.60% 43.60% 53.77%
Short-Term Debt to Total Capital
2.36% 0.86% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
19.15% 26.39% 38.75% 11.97% 13.74% 17.58% 28.91% - 41.60% 43.60% 53.77%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Common Equity to Total Capital
78.49% 72.74% 61.25% 88.03% 86.26% 82.42% 71.09% - 58.40% 56.40% 46.23%
Debt to EBITDA
-0.26 -0.23 -0.21 -0.20 -0.18 -0.15 -0.27 - -0.48 -0.48 -0.48
Net Debt to EBITDA
0.98 0.65 0.38 1.52 1.15 0.75 0.74 - 0.69 0.72 0.53
Long-Term Debt to EBITDA
-0.23 -0.22 -0.21 -0.20 -0.18 -0.15 -0.27 - -0.48 -0.48 -0.48
Debt to NOPAT
-0.38 -0.34 -0.31 -0.28 -0.26 -0.22 -0.39 - -0.69 -0.69 -0.69
Net Debt to NOPAT
1.42 0.96 0.55 2.19 1.66 1.08 1.07 - 0.99 1.04 0.76
Long-Term Debt to NOPAT
-0.34 -0.33 -0.31 -0.28 -0.26 -0.22 -0.39 - -0.69 -0.69 -0.69
Altman Z-Score
6.20 -0.60 -3.28 20.66 16.15 14.20 8.90 - 9.78 10.91 7.80
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
6.58 6.04 3.88 9.61 10.25 6.33 6.30 - 8.64 7.02 5.41
Quick Ratio
6.36 5.77 3.53 9.32 9.70 5.85 5.96 - 8.05 6.81 5.17
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-32 -31 -37 -35 -57 -73 -57 -60 -66 -46 -51
Operating Cash Flow to CapEx
-216,456.52% -223,618.18% -169,209.68% -225,059.09% -29,031.37% -35,786.51% -82,051.19% - -120,736.76% -7,030,700.00% -80,997.03%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 -60.79 -42.90 - -28.84 -10.20 -10.91
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 -63.80 -51.67 - -35.67 -15.56 -17.65
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -63.98 -51.73 - -35.69 -15.56 -17.68
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.37
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 294,897.19
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 -294,897.19
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-5.56 -6.80 -9.77 -18 -2.30 -12 -25 -22 -7.32 -42 -49
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 -0.02
Increase / (Decrease) in Invested Capital
-8.76 -10 -8.76 -14 3.26 -5.16 -15 -3.87 -5.02 -30 -24
Enterprise Value (EV)
1,195 524 552 3,659 2,729 3,118 3,310 - 5,364 6,295 5,667
Market Capitalization
1,383 664 641 4,046 3,044 3,363 3,580 - 5,648 6,591 5,885
Book Value per Share
$2.35 $1.68 $0.99 $3.94 $3.30 $2.46 $2.55 $2.41 $2.40 $2.12 $1.39
Tangible Book Value per Share
$2.35 $1.68 $0.99 $3.94 $3.30 $2.46 $2.55 $2.41 $2.40 $2.12 $1.39
Total Capital
233 184 129 419 362 283 345 345 473 450 365
Total Debt
50 50 50 50 50 50 100 100 197 196 196
Total Long-Term Debt
45 48 50 50 50 50 100 100 197 196 196
Net Debt
-188 -140 -89 -387 -315 -245 -270 -268 -283 -296 -217
Capital Expenditures (CapEx)
0.02 0.02 0.03 0.02 0.27 0.22 0.08 0.03 0.07 0.00 0.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-24 -23 -26 -33 -17 -26 -41 -38 -24 -57 -60
Debt-free Net Working Capital (DFNWC)
215 168 114 404 348 269 329 330 456 435 353
Net Working Capital (NWC)
209 166 114 404 348 269 329 330 456 435 353
Net Nonoperating Expense (NNE)
16 17 19 18 21 32 30 27 34 34 33
Net Nonoperating Obligations (NNO)
-188 -140 -89 -387 -315 -245 -270 -268 -283 -296 -217
Total Depreciation and Amortization (D&A)
-1.24 -0.76 -0.19 -0.90 -1.06 -0.96 -0.21 0.33 0.20 0.27 0.03
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -10,577.89%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 61,983.33%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 61,983.33%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.59) ($0.60) ($0.66) ($0.62) ($0.67) ($0.98) ($0.90) ($0.74) ($0.83) ($0.84) ($0.81)
Adjusted Weighted Average Basic Shares Outstanding
95.89M 96.81M 97.05M 99.84M 111.84M 112.70M 113.73M 114.70M 127.28M 130.61M 132.37M
Adjusted Diluted Earnings per Share
($0.59) ($0.60) ($0.66) ($0.62) ($0.67) ($0.98) ($0.90) ($0.74) ($0.83) ($0.84) ($0.81)
Adjusted Weighted Average Diluted Shares Outstanding
95.89M 96.81M 97.05M 99.84M 111.84M 112.70M 113.73M 114.70M 127.28M 130.61M 132.37M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
79.75M 80.03M 93.61M 94.68M 94.95M 96.13M 102.01M 114.88M 119.83M 121.79M 122.00M
Normalized Net Operating Profit after Tax (NOPAT)
-41 -42 -45 -49 -54 -78 -72 -64 -71 -76 -74
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -13,025.04%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% -18,813.86%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 -93.06 -77.68 - -44.66 -24.23 -23.03
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 -65.07 -54.34 - -31.02 -16.87 -16.02
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -93.24 -77.74 - -44.69 -24.23 -23.05
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -65.25 -54.40 - -31.05 -16.87 -16.04
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Scholar Rock remains a development-stage biotechnology company with no reported revenue. Total revenue was $0 in each provided income statement, leaving the company dependent on financing and investment income while it funds research and development. Net losses have generally widened over the period, reaching $109.9 million in Q2 2026 compared with $66.5 million in Q4 2024 and $43.3 million in Q3 2022.

  • Substantial liquidity: Cash and short-term investments totaled $492.1 million at June 30, 2026, up from $295.0 million at June 30, 2025 and $139.5 million at September 30, 2024.
  • Improved near-term funding position: Q2 2026 operating cash use declined to $70.3 million from $82.1 million in Q1 2026 and $76.9 million in Q2 2025. At the Q2 pace, the company held roughly seven quarters of cash and short-term investments before considering changes in spending or future financing.
  • Strong current-asset coverage: Total current assets of $507.2 million substantially exceeded total current liabilities of $72.2 million in Q2 2026. The company also reported $253.8 million of total equity.
  • Investment income provides some offset: Interest and investment income was $4.1 million in Q2 2026, helping partially offset $4.5 million of interest expense and the company’s operating deficit.
  • Operating expenses declined modestly year over year: Total operating expenses fell to $108.9 million in Q2 2026 from $112.1 million in Q2 2025, although the reduction was limited and expenses remained well above 2024 and 2023 levels.
  • Q2 cash increased slightly: Cash and equivalents rose by $7.3 million during Q2 2026, but this was primarily supported by $83.1 million of financing cash flow. Operating activities consumed $70.3 million and investing activities used another $5.5 million.
  • Financing activity remains important: Scholar Rock raised $62.8 million through common-equity issuance in Q2 2026, following $98.0 million in Q1 2026 and $91.7 million in Q3 2025. The company’s ability to fund development therefore continues to depend partly on access to capital markets.
  • No commercial revenue is evident: The company reported no revenue, cost of revenue, or gross profit in the available quarters. Until a product is approved and commercialized, financial performance will remain driven by research spending, financing, and investment returns.
  • Losses remain substantial: Q2 2026 net loss attributable to common shareholders was $109.9 million, or $0.84 per share, compared with a $105.5 million loss, or $0.83 per share, in Q1 2026. Research and development expense increased to $58.2 million from $51.8 million in Q1.
  • Debt and share dilution have increased: Long-term debt reached $196.2 million in Q2 2026, nearly four times the $49.8 million reported in Q2 2025. Weighted-average basic shares rose to 130.6 million from 112.7 million a year earlier, increasing dilution risk for existing shareholders.

Overall, Scholar Rock’s balance sheet is considerably stronger than it was in 2023 and 2024 because of substantial equity and debt financing. However, the company continues to generate no revenue, consume significant operating cash, and record sizable losses. Investors should focus on clinical and regulatory progress, the pace of cash burn, additional financing needs, and whether future product commercialization can eventually replace external funding.

11/19/26 05:34 PM ETAI Generated. May Contain Errors.

Scholar Rock Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Scholar Rock's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Scholar Rock's net income appears to be on a downward trend, with a most recent value of -$377.94 million in 2025, falling from -$25.00 million in 2017. The previous period was -$246.29 million in 2024. Check out Scholar Rock's forecast to explore projected trends and price targets.

Scholar Rock's total operating income in 2025 was -$384.65 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $384.65 million

Over the last 8 years, Scholar Rock's total revenue changed from $0.00 in 2017 to $0.00 in 2025, a change of 0.0%.

In the past 13 quarters, Scholar Rock's cash and equivalents has ranged from $67.60 million in Q3 2023 to $437.09 million in Q2 2026, and is currently $366.27 million as of their latest financial filing in Q3 2026.

Scholar Rock had total debt of $99.71 million at the end of 2025, a 98.8% increase from 2024, and a 9,496.6% increase since 2017.

Over the last 8 years, Scholar Rock's book value per share changed from -32.75 in 2017 to 2.41 in 2025.



Financial statements for NASDAQ:SRRK last updated on 11/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners